Literature DB >> 7795781

Determination of berberine in plasma, urine and bile by high-performance liquid chromatography.

C M Chen1, H C Chang.   

Abstract

A high-performance liquid chromatographic method for the determination of berberine in plasma, urine and bile samples is described. Plasma samples were pretreated by protein precipitation with acetonitrile and urine and bile samples were pretreated by organic solvent extraction using 5% 2-propanol in methylene chloride. Berberine was determined in all samples using an octyl reversed-phase column with a mobile phase of 60-63% acetonitrile in 0.1% phosphoric acid (pH 6.0) and with UV detection at 267 nm. The detection limits for berberine in plasma, urine and bile were 18.1 ng/ml, 2.3 ng/ml and 90.4 ng/ml, respectively. The recoveries of berberine by simple deproteinization of plasma and by solvent extraction of urine were 78.3 and 82.9%, respectively. The intra-day and inter-day accuracy and precision for plasma reported as coefficients of variation and relative errors were both less then 6%. The applicability of the assay to pharmacokinetic and bioavailability studies was demonstrated by the determination of berberine in plasma, urine and bile after intravenous and intramuscular administration to rabbits at a dose of 2 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795781     DOI: 10.1016/0378-4347(94)00517-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  15 in total

1.  The study of absorption kinetics of berberine based on portal vein in rat, and the influence of verapamil and borneol to its absorption ability by UHPLC method.

Authors:  Liang Zou; Rui Li; Ping Wang; Yan Xiao; Li-Jia Xu; Yu-Xin He; Gang Zhao; Lian-Xin Peng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-09-07       Impact factor: 2.441

2.  A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine.

Authors:  Shenghua Gu; Bei Cao; Runbin Sun; Yueqing Tang; Janice L Paletta; Xiaolei Wu; Xiao-Lei Wu; Linsheng Liu; Weibin Zha; Chunyan Zhao; Yan Li; Jason M Ridlon; Jason M Radlon; Phillip B Hylemon; Huiping Zhou; Jiye Aa; Guangji Wang
Journal:  Mol Biosyst       Date:  2014-11-20

3.  Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).

Authors:  Anne T Nies; Elke Herrmann; Manuela Brom; Dietrich Keppler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

4.  Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.

Authors:  F F Zhou; S Wu; J D Klena; H H Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-13       Impact factor: 3.267

5.  Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.

Authors:  Chandraiah Godugu; Apurva R Patel; Ravi Doddapaneni; Jaganmohan Somagoni; Mandip Singh
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

6.  Tissue distribution of berberine and its metabolites after oral administration in rats.

Authors:  Xiang-Shan Tan; Jing-Yi Ma; Ru Feng; Chao Ma; Wen-Jing Chen; Yu-Peng Sun; Jie Fu; Min Huang; Chi-Yu He; Jia-Wen Shou; Wen-Yi He; Yan Wang; Jian-Dong Jiang
Journal:  PLoS One       Date:  2013-10-31       Impact factor: 3.240

7.  Design, synthesis, and anticancer activity of novel berberine derivatives prepared via CuAAC "click" chemistry as potential anticancer agents.

Authors:  Xin Jin; Tian-Hua Yan; Lan Yan; Qian Li; Rui-Lian Wang; Zhen-Lin Hu; Yuan-Ying Jiang; Qing-Yan Sun; Yong-Bing Cao
Journal:  Drug Des Devel Ther       Date:  2014-08-06       Impact factor: 4.162

8.  Determination of hydrastine and berberine in goldenseal raw materials, extracts, and dietary supplements by high-performance liquid chromatography with UV: collaborative study.

Authors:  Paula N Brown; Mark C Roman
Journal:  J AOAC Int       Date:  2008 Jul-Aug       Impact factor: 2.028

9.  Exploratory Pharmacokinetics of Geniposide in Rat Model of Cerebral Ischemia Orally Administered with or without Baicalin and/or Berberine.

Authors:  Linmei Pan; Wenzhe Wang; Feiyan Shi; Jing Zhou; Meng Zhang; Huaxu Zhu; Mingfei Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

10.  The Effect of Ultrafine Process on the Dissolution, Antibacterial Activity, and Cytotoxicity of Coptidis rhizoma.

Authors:  Zhen-Yu Jiang; Hai-Ying Deng; Zhi-Jun Yu; Jun-Yan Ni; Si-He Kang
Journal:  Pharmacognosy Res       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.